GRDN

Guardian Pharmacy Services

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 72.7%
Negative

Positive
MarketBeat
21 days ago
Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
Guardian Pharmacy Services Inc. NYSE: GRDN, a small-cap healthcare company, made waves in Tuesday's session after reporting better-than-expected earnings that sent the stock surging on above-average volume.
Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
Positive
The Motley Fool
22 days ago
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday
Barely one year after its IPO, the company is doing a decent job finding its niche. This was strongly evidenced by its 20% revenue jump in the third quarter.
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday
Positive
Zacks Investment Research
23 days ago
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to a loss of $2 per share a year ago.
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
Neutral
Seeking Alpha
23 days ago
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Guardian Pharmacy Services, Inc. ( GRDN ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Ashley Stockton - Head of Investor Relations & Senior Director Fred Burke - CEO, President & Director David Morris - CFO, Executive VP & Director Conference Call Participants John Ransom - Raymond James & Associates, Inc., Research Division David MacDonald - Truist Securities, Inc., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good day, everyone, and welcome to Guardian Pharmacy's Third Quarter Earnings Call. [Operator Instructions] I will now hand the call over to Ashley Stockton.
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Neutral
Business Wire
23 days ago
Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss).
Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance
Neutral
Zacks Investment Research
29 days ago
Guardian Pharmacy Services (GRDN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Guardian Pharmacy Services (GRDN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Stephens Investment Conference in Nashville, TN, on Wednesday, November 19, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat at 11:00 a.m. CT (12:00 p.m. ET) the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be acces.
Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) (“Guardian”), one of the nation's leading long-term care (LTC) pharmacy services companies, today announced that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC). The registration statement relates to (i) the possible issuance and sale of up to 1,020,000 shares of Class A common stock by Guardian and (ii) the potential resale of up to 4,980,000 outstanding shares.
Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced today that it will release its third quarter 2025 results on Monday, November 10th, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participa.
Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call
Neutral
Seeking Alpha
2 months ago
Guardian Pharmacy Services, Inc. (GRDN) Presents at Jefferies 2025 Healthcare Services Conference Transcript
Guardian Pharmacy Services, Inc. (NYSE:GRDN ) Jefferies 2025 Healthcare Services Conference September 30, 2025 4:35 PM EDT Company Participants Fred Burke - CEO, President & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Presentation Brian Tanquilut Jefferies LLC, Research Division Good afternoon, and we're here for our last presentation of the day, but saving the best for last, right? So we have a Guardian Pharmacy Services as our next presenter.
Guardian Pharmacy Services, Inc. (GRDN) Presents at Jefferies 2025 Healthcare Services Conference Transcript